PHY906
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PHY906, covering 2007-03-28 to 2015-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma [Phase 1, Phase 2]